These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11430883)

  • 21. Prevalence of arylsulfatase A pseudodeficiency allele in metachromatic leukodystrophy patients from Poland.
    Lugowska A; Czartoryska B; Tylki-Szymańska A; Bisko M; Zimowski JG; Berger J; Molzer B
    Eur Neurol; 2000; 44(2):104-7. PubMed ID: 10965162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of metachromatic leukodystrophy.
    Gieselmann V; Kreysing J; von Figura K
    Gene Ther; 1994; 1 Suppl 1():S87. PubMed ID: 8542433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.
    Blomqvist M; Gieselmann V; Månsson JE
    Lipids Health Dis; 2011 Feb; 10():28. PubMed ID: 21299873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A spontaneously immortalized Schwann cell line to study the molecular aspects of metachromatic leukodystrophy.
    Saravanan K; Büssow H; Weiler N; Gieselmann V; Franken S
    J Neurosci Methods; 2007 Apr; 161(2):223-33. PubMed ID: 17204333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexin II is essential for normal neurological function in mice.
    Glynn D; Bortnick RA; Morton AJ
    Hum Mol Genet; 2003 Oct; 12(19):2431-48. PubMed ID: 12915444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The APP-interacting protein FE65 is required for hippocampus-dependent learning and long-term potentiation.
    Wang Y; Zhang M; Moon C; Hu Q; Wang B; Martin G; Sun Z; Wang H
    Learn Mem; 2009 Sep; 16(9):537-44. PubMed ID: 19713352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
    Matthes F; Stroobants S; Gerlach D; Wohlenberg C; Wessig C; Fogh J; Gieselmann V; Eckhardt M; D'Hooge R; Matzner U
    Hum Mol Genet; 2012 Jun; 21(11):2599-609. PubMed ID: 22388935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transduced fibroblasts and metachromatic leukodystrophy lymphocytes transfer arylsulfatase A to myelinating glia and deficient cells in vitro.
    Sangalli A; Taveggia C; Salviati A; Wrabetz L; Bordignon C; Severini GM
    Hum Gene Ther; 1998 Sep; 9(14):2111-9. PubMed ID: 9759937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy for metachromatic leukodystrophy.
    Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Matalon R; Eto Y
    Acta Paediatr Jpn; 1996 Apr; 38(2):193-201. PubMed ID: 8677802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoform-specific knockout of FE65 leads to impaired learning and memory.
    Wang B; Hu Q; Hearn MG; Shimizu K; Ware CB; Liggitt DH; Jin LW; Cool BH; Storm DR; Martin GM
    J Neurosci Res; 2004 Jan; 75(1):12-24. PubMed ID: 14689444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocalcin-deficient mice display a defect in cAMP response element-binding protein activation associated with impaired spatial and associative memory.
    Kobayashi M; Masaki T; Hori K; Masuo Y; Miyamoto M; Tsubokawa H; Noguchi H; Nomura M; Takamatsu K
    Neuroscience; 2005; 133(2):471-84. PubMed ID: 15878804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a new Arylsulfatase A (ARSA) gene mutation in Tunisian patients with metachromatic leukodystrophy (MLD).
    Dorboz I; Eymard-Pierre E; Kefi R; Abdelhak S; Miladi N; Boespflug-Tanguy O;
    J Neurol Sci; 2009 Dec; 287(1-2):278-80. PubMed ID: 19699491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy.
    Eckhardt M; Hedayati KK; Pitsch J; Lüllmann-Rauch R; Beck H; Fewou SN; Gieselmann V
    J Neurosci; 2007 Aug; 27(34):9009-21. PubMed ID: 17715338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrovirally expressed human arylsulfatase A corrects the metabolic defect of arylsulfatase A-deficient mouse cells.
    Matzner U; Habetha M; Gieselmann V
    Gene Ther; 2000 May; 7(9):805-12. PubMed ID: 10822308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis.
    D'Hooge R; Lüllmann-Rauch R; Beckers T; Balschun D; Schwake M; Reiss K; von Figura K; Saftig P
    J Neurosci; 2005 Jul; 25(28):6539-49. PubMed ID: 16014715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inability to acquire spatial information and deploy spatial search strategies in mice with lesions in dorsomedial striatum.
    Pooters T; Gantois I; Vermaercke B; D'Hooge R
    Behav Brain Res; 2016 Feb; 298(Pt B):134-41. PubMed ID: 26548360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.
    Hess B; Saftig P; Hartmann D; Coenen R; Lüllmann-Rauch R; Goebel HH; Evers M; von Figura K; D'Hooge R; Nagels G; De Deyn P; Peters C; Gieselmann V
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14821-6. PubMed ID: 8962139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a B-vitamin-deficient diet on exploratory activity, motor coordination, and spatial learning in young adult Balb/c mice.
    Lalonde R; Barraud H; Ravey J; Guéant JL; Bronowicki JP; Strazielle C
    Brain Res; 2008 Jan; 1188():122-31. PubMed ID: 18061153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sema4D/CD100 deficiency leads to superior performance in mouse motor behavior.
    Yukawa K; Tanaka T; Takeuchi N; Iso H; Li L; Kohsaka A; Waki H; Miyajima M; Maeda M; Kikutani H; Kumanogoh A
    Can J Neurol Sci; 2009 May; 36(3):349-55. PubMed ID: 19534337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activity of aryl sulfatase A enzyme in patients with schizophrenic disorders].
    Alvarez Leal M; Castillo Solís T; Pérez Zuno JA; Vargas Ramos I; Sepúlveda García R; Zúñiga Charles MA
    Rev Invest Clin; 1995; 47(5):387-92. PubMed ID: 8584809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.